JP2019206562A5 - - Google Patents

Download PDF

Info

Publication number
JP2019206562A5
JP2019206562A5 JP2019140640A JP2019140640A JP2019206562A5 JP 2019206562 A5 JP2019206562 A5 JP 2019206562A5 JP 2019140640 A JP2019140640 A JP 2019140640A JP 2019140640 A JP2019140640 A JP 2019140640A JP 2019206562 A5 JP2019206562 A5 JP 2019206562A5
Authority
JP
Japan
Prior art keywords
configuration
kidney disease
chronic kidney
ferric citrate
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019140640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019206562A (ja
JP6828100B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019206562A publication Critical patent/JP2019206562A/ja
Publication of JP2019206562A5 publication Critical patent/JP2019206562A5/ja
Application granted granted Critical
Publication of JP6828100B2 publication Critical patent/JP6828100B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019140640A 2013-11-04 2019-07-31 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 Active JP6828100B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361899866P 2013-11-04 2013-11-04
US61/899,866 2013-11-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016552432A Division JP2016535780A (ja) 2013-11-04 2014-11-03 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021007091A Division JP2021073230A (ja) 2013-11-04 2021-01-20 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Publications (3)

Publication Number Publication Date
JP2019206562A JP2019206562A (ja) 2019-12-05
JP2019206562A5 true JP2019206562A5 (https=) 2020-01-23
JP6828100B2 JP6828100B2 (ja) 2021-02-10

Family

ID=53005244

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016552432A Pending JP2016535780A (ja) 2013-11-04 2014-11-03 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
JP2019140640A Active JP6828100B2 (ja) 2013-11-04 2019-07-31 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
JP2021007091A Pending JP2021073230A (ja) 2013-11-04 2021-01-20 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016552432A Pending JP2016535780A (ja) 2013-11-04 2014-11-03 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021007091A Pending JP2021073230A (ja) 2013-11-04 2021-01-20 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Country Status (15)

Country Link
US (3) US20160256486A1 (https=)
EP (2) EP3747432A1 (https=)
JP (3) JP2016535780A (https=)
KR (1) KR102392441B1 (https=)
CN (1) CN105873583A (https=)
AU (1) AU2014341975A1 (https=)
BR (1) BR112016009901A8 (https=)
CA (1) CA2928200A1 (https=)
EA (1) EA201690926A1 (https=)
HK (1) HK1223031A1 (https=)
IL (1) IL245317A0 (https=)
MX (1) MX2016005734A (https=)
SG (1) SG11201603091QA (https=)
TW (2) TWI744215B (https=)
WO (1) WO2015066593A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011011541A1 (en) 2009-07-21 2011-01-27 Henry Trong Le Ferric citrate dosage forms
EP3003327B1 (en) 2013-06-05 2017-08-09 Tricida Inc. Proton-binding polymers for oral administration
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
RS61409B1 (sr) 2014-12-10 2021-03-31 Tricida Inc Polimeri koji vezuju protone za oralnu primenu opis
CN109414453B (zh) 2016-05-06 2023-02-17 特里赛达公司 用于治疗酸碱失衡的组合物
CA3080651A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
MX2021004640A (es) 2018-10-29 2021-05-28 Pharmacosmos Holding As Tratamiento de la deficiencia de hierro con carboximaltosa ferrica.
EA202191858A1 (ru) * 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
EP4347022A1 (en) * 2021-05-27 2024-04-10 Keryx Biopharmaceuticals, Inc. Pediatric formulations of ferric citrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE351366B (https=) * 1965-06-08 1972-11-27 Teikoku Hormone Mfg Co Ltd
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
CA2619591C (en) * 2005-08-18 2020-03-24 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
KR20080106506A (ko) * 2006-01-30 2008-12-08 글로보아시아 엘엘씨 만성 신장병의 치료 방법
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
WO2011011541A1 (en) * 2009-07-21 2011-01-27 Henry Trong Le Ferric citrate dosage forms
WO2012006473A1 (en) * 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US20130345303A1 (en) * 2012-06-21 2013-12-26 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of chronic kidney disease patients

Similar Documents

Publication Publication Date Title
JP2019206562A5 (https=)
JP2017002083A5 (https=)
FI4243825T3 (fi) Omekamtiivimekarbiili sydämen vajaatoiminnan hoitoon valikoiduilla potilasryhmillä
JP2011522876A (ja) 永続性心房細動を予防するためのドロネダロン
JPH0649651B2 (ja) 心筋虚血治療用医薬組成物
Kiuchi et al. Long-term use of ipragliflozin improved cardiac sympathetic nerve activity in a patient with heart failure: a case report
Sağ et al. Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine
CN106176703A (zh) 丹酚酸a在制备预防和/或治疗肺动脉高压中的药物用途
CN105748464A (zh) 一种治疗射血分数保留的心力衰竭的药物组合物及其应用
WO2023005002A1 (zh) 枸橼酸爱地那非在制备预防和或治疗肺动脉高压的药物中的用途
CN101588807B (zh) D-核糖在制备治疗心律失常的药物中的应用
Price et al. A case of subendocardial infarction
Kanlop et al. Granulocyte colony‐stimulating factor stabilizes cardiac electrophysiology and decreases infarct size during cardiac ischaemic/reperfusion in swine
US3329567A (en) Synergistic effect of adenylic nucleotides in digitalis therapy
Aypar et al. Voriconazole‐induced QT interval prolongation and torsades de pointes
Fernández-Ruiz Low-dose colchicine shows promise in chronic coronary disease
Sadeghian et al. Short QT syndrome and idiopathic ventricular tachycardia in a 28-year-old young man: a potential disease-specific link?
Sahin et al. A young patient with coronary artery anomaly, whose left anterior descending artery originated from the pulmonary artery, underwent cardiac arrest: case report-online article
JP6028983B2 (ja) ビダラビンによる心房細動治療
EP3842056B1 (en) Use of ghrp-6 as late cardioprotective and cardiac restoration medicament
WO2011141872A1 (en) Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter
Lim Benefit of controlling heart rhythm soon after AF diagnosis
JP2007008845A (ja) 慢性心不全治療および／または予防薬
Biyik et al. Left ventricular steal syndrome caused by multiple plexiform coronary artery fistulae: case report, literature review and treatment
Spath Jr et al. Preservation of cardiac cellular integrity by methylpred-nisolone in acute myocardial ischemia